Randomized Phase

Related by string. randomized Phase * randomizing . randomizer : randomized controlled trial . randomized controlled trials / phases . phase : Phase III clinical trials . Phase III trials * randomized Phase IIb . multicenter randomized Phase III . Randomized Phase II . randomized Phase III . multicenter randomized Phase . randomized Phase 2b . Randomized Phase III *

Related by context. Frequent words. (Click for all words.) 87 Pivotal Phase 80 Initiates Phase 80 Pivotal Phase III 80 Clinical Trial Results 77 Drug Candidate 77 Phase III Clinical Trial 77 Completes Enrollment 76 Metastatic Melanoma 76 Phase III Trial 76 Chronic Hepatitis C 75 Well Tolerated 75 Metastatic Colorectal Cancer 74 Presents Positive 74 Preclinical Data 74 placebo controlled Phase 74 Patient Enrollment 74 Pivotal Trial 73 Monotherapy 73 multicenter Phase 72 Bortezomib 72 Dasatinib 72 Patients Treated 71 Pulmonary Arterial Hypertension 71 Tesetaxel 71 metastatic castration resistant 71 phase IIb clinical 70 Meta Analysis 70 Combination Therapy 70 Benign Prostatic Hyperplasia 70 Elderly Patients 70 liposomal formulation 70 Bevacizumab 70 Natalizumab 70 Advanced Prostate Cancer 70 elotuzumab 70 Postmenopausal Women 69 Phase Ib clinical 69 Epratuzumab 69 PRECiSE 69 Solid Tumors 69 Voreloxin 69 Multicenter 69 Heart Failure Patients 69 HGS ETR1 69 Diabetic Macular Edema 68 Chronic Lymphocytic Leukemia 68 Cardiovascular Events 68 KRN# 68 Inhibits 68 nab paclitaxel 68 phase IIb 68 Acute Myocardial Infarction 68 Irinotecan 68 Amrubicin 68 RADIANT 68 Tolerability 68 registrational trial 68 FDA Accepts 68 MKC# 68 Immunogenicity 68 Low Dose 68 Adalimumab 68 Prostate Cancer Patients 68 Phase 2a clinical 67 SABCS 67 Gemzar ® 67 Laquinimod 67 Monoclonal Antibody 67 Traficet EN 67 Allergic Rhinitis 67 RNAi Therapeutics 67 Alemtuzumab 67 Bavituximab 67 CD# [004] 67 phase IIa 67 Overactive Bladder 67 Pirfenidone 67 metastatic hormone refractory 67 Vandetanib 67 Sym# 67 Panitumumab 67 Perifosine 67 Extended Release 66 forodesine 66 Generic Version 66 Ofatumumab 66 J Natl Cancer Inst 66 Enoxaparin 66 Naproxcinod 66 Diabetic Patients 66 Study Demonstrates 66 Erlotinib 66 plus dexamethasone 66 Pioglitazone 66 ganetespib 66 Cethromycin 66 Randomized Controlled Trial 66 DURATION 66 J Am Coll 66 FOLFOX 66 DDP#

Back to home page